Thomas R Pieber
Endocrinology — Geriatrische Gesundheitszentren, Austria
Thomas R Pieber
LeadR Profile
Endocrinology
Subspecialties: Cardiology - Biochemistry - Dermatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1993 - 2026
Number : 675
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Transcriptomics of type 1 diabetes progression: a validation study in newly diagnosed patients. diabetes mellitus, genes, biomedical research, disease progression, diagnosis, therapeutics, diabetes mellitus, type 1, gene expression | EBioMedicine | 2026 | 0 |
| Exercise or Fasting in Individuals With Type 2 Diabetes Receiving Once-Weekly Basal Insulin Icodec. diabetes mellitus, exercise, fasting, insulin, carbohydrates, diabetes mellitus, type 2 | Diabetes Obes Metab | 2026 | 0 |
| Presenilin-1 controls glycolysis and identity of pancreatic beta cells. cells, biological science disciplines, insulin-secreting cells, homeostasis, presenilins, presenilin-1 | Commun Biol | 2026 | 0 |
| Targeting Inflammation in Obesity and the Cardiovascular-Kidney-Metabolic (CKM) Syndrome Spectrum: A Narrative Review. diabetes mellitus, multiple chronic conditions, kidney, liver, obesity, therapeutics, peroxisome proliferator-activated receptors | Obes Facts | 2026 | 0 |
| Enzymatic 2-Hydroxybutyrate Measurement for Dysglycemia Screening Beyond Conventional Fasting Measures. diabetes mellitus, research design, fasting, biomarkers | Diabetes Care | 2026 | 0 |
Clinical Studies 75
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening NCT06512311 — brain neoplasms, pharmaceutical preparations, brain, neoplasms, drug evaluation, preclinical, glioblastoma, therapeutics | N/A | Recruiting | 2024 |
| Metabolic Control of Aging and Disease the MetAGE Deep Phenotyping Cohort NCT06511297 — tomography, aging, brain, phenotype, magnetic resonance imaging, tomography, optical coherence, obesity, patient reported outcome measures, metabolic syndrome, male | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map